Phoenix Pharma Belgium
Avenue Emile Vandervelde 82
1200 Woluwe-Saint-Lambert
BE
Public Limited Company
Juridical SituationNormal situation
Established12/28/1983
Large
Wholesale trade excluding repair of motor vehicles and motorcycles
Manufacture of basic pharmaceutical products and pharmaceutical preparations
ESG Risk Cases
18/2/2022Pharma-Belgium Belmedis fined for anti-competitive practicesHIGH ALERTRESOLVED
Accusation
The Belgian Competition Authority (BMA) is taking action against medicine distributors Febelco and P…
Timeline
First report on 18/2/2022 by Het Laatste Nieuws.
Last update on 18/2/2022.
Involved Companies
PHOENIX Pharma Belgium
Sentiment Attention Over Time
The Sentiment Attention is produced by AI models developed by Sentometrics. Articles are connected to companies based on public information like company names, sectors, locations, linked companies, and company directors. Themes are assigned using keywords, and sentiment is analyzed with the help of AI prompts. A human team reviews and helps the system learn and improve over time.
Recent Relevant News
| Date | Sentiment | Theme | Headline | Source |
|---|---|---|---|---|
Date 29/5/2024 | Sentiment Positive | Theme Governance Social | Title Positive Update - May 29 | Source Source 1 |
Date 28/5/2024 | Sentiment Positive | Theme Financial health | Title Positive Update - May 28 | Source Source 2 |
Unlock 25+ years of newsUnlock | ||||
Often Mentioned With
Company Network
Financials
as of 31/3/2023
Key highlights
- Phoenix Pharma Belgium turnover grew to €1.1B (+€47.4M), with a net result of -€2.6M (-0% margin).
- Financial position remains leveraged with total assets of €220.9M and a solvency ratio of 9%.
- Workforce efficiency is strong with 560.1 FTE generating an average turnover of €2M per employee.
Frequently Asked Questions
The VAT number for Phoenix Pharma Belgium is BE 0425353116.
Phoenix Pharma Belgium was established on 28 December 1983 and has been operating for 42 years.
The registered address for Phoenix Pharma Belgium is Avenue Emile Vandervelde 82, 1200 Woluwe-Saint-Lambert, BE.
The latest annual accounts for Phoenix Pharma Belgium for the year 2023 were filed on 11/10/2023.
Based on the most recent annual accounts, Phoenix Pharma Belgium reports 560.1 FTEs.
In its latest annual accounts, Phoenix Pharma Belgium reported a turnover of €1.1B.
Phoenix Pharma Belgium is registered under the following NACE activities: Wholesale trade excluding repair of motor vehicles and motorcycles, Manufacture of basic pharmaceutical products and pharmaceutical preparations.
No. We currently do not list any unresolved ESG risk cases for Phoenix Pharma Belgium.